CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock, Common	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022		78,350,984	(2,766,073)
Beginning balance at Dec. 31, 2022	$ 68,088	$ 78	$ (3)	$ 771,052	$ (692,362)	$ (10,677)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		18,687
Common stock issued upon exercise of stock options	130			130
Common stock issued upon vesting of restricted stock units (in shares)		413,252
Common stock issued upon vesting of restricted stock units	1	$ 1
Stock-based compensation	9,560			9,560
Common stock issued under Employee Stock Purchase Plan (in shares)		87,794
Common stock issued under Employee Stock Purchase Plan (ESPP)	724			724
Issuance of common stock in connection with acquisitions (Note 9)	380			380
Activity related to divestiture (Note 20)	2,732			66,775	(64,100)	57
Net income (loss)	(17,420)				(17,420)
Other comprehensive loss	809					809
Ending balance (in shares) at Mar. 31, 2023		78,870,717	(2,766,073)
Ending balance at Mar. 31, 2023	65,004	$ 79	$ (3)	848,621	(773,882)	(9,811)
Beginning balance (in shares) at Dec. 31, 2022		78,350,984	(2,766,073)
Beginning balance at Dec. 31, 2022	68,088	$ 78	$ (3)	771,052	(692,362)	(10,677)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(6,598)
Ending balance (in shares) at Jun. 30, 2023		80,312,090	(2,766,073)
Ending balance at Jun. 30, 2023	90,145	$ 80	$ (3)	862,553	(763,060)	(9,425)
Beginning balance (in shares) at Mar. 31, 2023		78,870,717	(2,766,073)
Beginning balance at Mar. 31, 2023	65,004	$ 79	$ (3)	848,621	(773,882)	(9,811)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		11,154
Common stock issued upon exercise of stock options	8			8
Common stock issued upon vesting of restricted stock units (in shares)		295,564
Common stock issued upon vesting of restricted stock units	0
Stock-based compensation	8,380			8,380
Common stock issued under Employee Stock Purchase Plan (in shares)		97,832
Common stock issued under Employee Stock Purchase Plan (ESPP)	397			397
Issuance of common stock in connection with acquisitions (in shares)		1,036,823
Issuance of common stock in connection with acquisitions (Note 9)	5,148	$ 1		5,147
Net income (loss)	10,822				10,822
Other comprehensive loss	386					386
Ending balance (in shares) at Jun. 30, 2023		80,312,090	(2,766,073)
Ending balance at Jun. 30, 2023	90,145	$ 80	$ (3)	862,553	(763,060)	(9,425)
Beginning balance (in shares) at Dec. 31, 2023		90,603,519	(2,766,073)
Beginning balance at Dec. 31, 2023	48,138	$ 91	$ (3)	913,522	(856,988)	(8,484)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon vesting of restricted stock units (in shares)		432,701
Common stock issued upon vesting of restricted stock units	1			1
Stock-based compensation	8,251			8,251
Common stock issued under Employee Stock Purchase Plan (in shares)		95,603
Common stock issued under Employee Stock Purchase Plan (ESPP)	122			122
Net income (loss)	(35,631)				(35,631)
Other comprehensive loss	(1,698)					(1,698)
Ending balance (in shares) at Mar. 31, 2024		91,131,823	(2,766,073)
Ending balance at Mar. 31, 2024	19,183	$ 91	$ (3)	921,896	(892,619)	(10,182)
Beginning balance (in shares) at Dec. 31, 2023		90,603,519	(2,766,073)
Beginning balance at Dec. 31, 2023	48,138	$ 91	$ (3)	913,522	(856,988)	(8,484)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	6,164
Ending balance (in shares) at Jun. 30, 2024		91,752,520	(2,766,073)
Ending balance at Jun. 30, 2024	66,606	$ 92	$ (3)	927,529	(850,824)	(10,188)
Beginning balance (in shares) at Mar. 31, 2024		91,131,823	(2,766,073)
Beginning balance at Mar. 31, 2024	19,183	$ 91	$ (3)	921,896	(892,619)	(10,182)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon vesting of restricted stock units (in shares)		536,424
Common stock issued upon vesting of restricted stock units	2	$ 1		1
Stock-based compensation	5,762			5,762
Common stock issued under Employee Stock Purchase Plan (in shares)		84,273
Common stock issued under Employee Stock Purchase Plan (ESPP)	55			55
Activity related to divestiture (Note 20)	(185)			(185)
Net income (loss)	41,795				41,795
Other comprehensive loss	(6)					(6)
Ending balance (in shares) at Jun. 30, 2024		91,752,520	(2,766,073)
Ending balance at Jun. 30, 2024	$ 66,606	$ 92	$ (3)	$ 927,529	$ (850,824)	$ (10,188)